Debt-to-equity of PTC THERAPEUTICS, INC. from 31 Mar 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PTC THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2014 to 31 Dec 2025.
  • PTC THERAPEUTICS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was -1538%, a 449% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PTC THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -1538% -1258% -449% 31 Dec 2025
Q3 2025 -686% -387% -130% 30 Sep 2025
Q2 2025 -447% -143% -47% 30 Jun 2025
Q1 2025 -345% -33% -10% 31 Mar 2025
Q4 2024 -280% +61% +18% 31 Dec 2024
Q3 2024 -299% +89% +23% 30 Sep 2024
Q2 2024 -304% +183% +38% 30 Jun 2024
Q1 2024 -312% +339% +52% 31 Mar 2024
Q4 2023 -342% +572% +63% 31 Dec 2023
Q3 2023 -388% +1141% +75% 30 Sep 2023
Q2 2023 -487% +4149% +90% 30 Jun 2023
Q1 2023 -652% -4226% -118% 31 Mar 2023
Q4 2022 -913% -2176% -172% 31 Dec 2022
Q3 2022 -1529% -2208% -325% 30 Sep 2022
Q2 2022 -4636% -5113% -1071% 30 Jun 2022
Q1 2022 3575% +3245% +985% 31 Mar 2022
Q4 2021 1263% +1009% +397% 31 Dec 2021
Q3 2021 679% +470% +224% 30 Sep 2021
Q2 2021 478% +311% +187% 30 Jun 2021
Q1 2021 329% +161% +96% 31 Mar 2021
Q4 2020 254% +95% +60% 31 Dec 2020
Q3 2020 209% +45% +27% 30 Sep 2020
Q2 2020 167% -5.2% -3% 30 Jun 2020
Q1 2020 168% +8.3% +5.2% 31 Mar 2020
Q4 2019 158% -4.7% -2.9% 31 Dec 2019
Q3 2019 165% +24% +17% 30 Sep 2019
Q2 2019 172% +42% +33% 30 Jun 2019
Q1 2019 160% +15% +11% 31 Mar 2019
Q4 2018 163% +20% +14% 31 Dec 2018
Q3 2018 141% +4% +2.9% 30 Sep 2018
Q2 2018 129% +5% +4% 30 Jun 2018
Q1 2018 145% +33% +30% 31 Mar 2018
Q4 2017 143% +50% +54% 31 Dec 2017
Q3 2017 137% +59% +76% 30 Sep 2017
Q2 2017 124% +61% +95% 30 Jun 2017
Q1 2017 111% +65% +143% 31 Mar 2017
Q4 2016 93% +62% +197% 31 Dec 2016
Q3 2016 78% +58% +298% 30 Sep 2016
Q2 2016 64% +53% +515% 30 Jun 2016
Q1 2016 46% +36% +385% 31 Mar 2016
Q4 2015 31% +23% +280% 31 Dec 2015
Q3 2015 20% +12% +162% 30 Sep 2015
Q2 2015 10% +2.8% +37% 30 Jun 2015
Q1 2015 9.5% -0.13% -1.3% 31 Mar 2015
Q4 2014 8.2% 31 Dec 2014
Q3 2014 7.5% 30 Sep 2014
Q2 2014 7.5% 30 Jun 2014
Q1 2014 9.6% 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.